Abstract
Acyclovir is an effective treatment for herpes simplex virus (HSV) infection. Its use produces improvement in symptoms and reduces the frequency of recurring disease. During chronic suppressive acyclovir therapy, breakthrough recurrences and asymptomatic viral shedding are common. Adverse reactions or signs of toxicity from acyclovir have been minimal. Early treatment does not prevent the establishment of latent HSV infection, the transmission of genital HSV infection, or asymptomatic viral shedding. Patient awareness of atypical lesions and modification of sexual activity are important aspects affecting transmission. Acyclovir resistance is being reported with increasing frequency, especially in patients infected with the human immunodeficiency virus. The development of additional antiviral agents would be beneficial in continuing the progress toward control of HSV infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Elion, G.: Selectivity of action of an antiherpetic agent 9-(2-hydroxyethoxymethyl) guanine. Proceedings of the National Academy of Sciences of the USA 1977, 74: 5716.
Dorsky, D. I., Crumpacker, C. S.: Drugs 5 years later. Annals of Internal Medicine 1987, 207 (Supplement 6): 859–874.
Pazin, G. H., Harger, J. H., Armstrong, J. A.: Leukocyte interferon for treating first episodes of genital herpes in women. Journal of Infectious Diseases 1987, 156: 891–898.
Mindel, A., Kinghorn, G., Allison, J. E.: Treatment of first attack genital herpes, acyclovir versus Inosine Pranobex. Lancet 1987, i: 1171–1173.
Sacks, S. L., Portnoy, J., Loweed, D.: Clinical course of recurrent genital herpes and treatment with foscarnate: results of a Canadian multicenter trial. Journal of Infectious Diseases 1987, 155: 178–186.
Corey, L., Adams, H. G., Brown, Z. A., Holmes, K. K.: Genital herpes simplex virus infection: clinical manifestations, course and complications. Annals of Internal Medicine 1983, 98: 958–972.
Bryson, Y. J., Dillon, M., Lovett, M., Acuma, G., Taylor, S., Cherry, J. D., Johnson, B. L., Wiesmeier, E., Growdon, W., Creagh-Kirk, T., Keeney, R.: Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir; a randomized double blind controlled trial in normal subjects. New England Journal of Medicine 1983, 308: 916–921.
Corey, L., Benedetti, J., Critchlow, C., Mertz, C., Douglas, J., Fife, K., Fahnlander, A., Remington, M. L., Winter, C., Dragavon, J.: Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous, and oral therapy. Journal of Antimicrobial Chemotherapy 1983, 12 (Supplement B): 79–88.
Corey, L., Fife, K. H., Benedetti, J. K., Winter, C. A., Fahnlander, A., Conner, J. D., Hintz, M. A., Holmes, K. K.: Intravenous acyclovir for the treatment of primary genital herpes. Annals of Internal Medicine 1983, 98: 914–921.
Fiddian, A. P., Kinghorn, G. R., Goldmeier, D., Reese, E., Rodin, P., Thin, R. N. T., deKonig, G. A. J.: Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy. Journal of Antimicrobial Chemotherapy 1983, 12 (Supplement B): 67–77.
Mertz, G. J., Critchlow, C. W., Benedetti, J., Reichman, R. C., Dolin, R., Connor, J., Redfield, D. C., Savoia, M. C., Richman, D. D., Tyrell, D. L., Miedzinski, L., Portnoy, J., Keeney, R. E.: Double blind placebo controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. Journal of the American Medical Association 1984, 252: 1147–1151.
Mindel, A., Adler, M. W., Sutherland, S., Fiddian, A. P.: Intravenous acyclovir treatment for primary genital herpes. Lancet 1982, i: 697–700.
Nilsen, A. E., Aasen, T., Halsos, A. M., Kinge, B. R., Tjotta, E. A. L., Wilkstrom, K., Fiddian, A. P.: Efficacy of oral acyclovir in treatment of initial and recurrent genital herpes. Lancet 1982, ii: 572–573.
Thin, R. N., Nabarro, J. M., Parker, J. D., Fiddian, A. P.: Topical acyclovir in the treatment of initial genital herpes. British Journal of Venereal Disease 1983, 59: 116–119.
Mindel, A., Weiler, I. V. D., Faherty, A., Sutherland, S., Fiddian, A. P., Adler, M. W.: Acyclovir in first attacks of genital herpes and prevention of recurrences. Genitourinary Medicine 1986, 62: 28–32.
Corey, L., Benedetti, J. K., Critchlow, C. W., Remington, M. L., Winter, C. A., Fahnlander, A. L., Smith, K., Salter, D., Keeney, R. E., Davis, L. G., Hintz, M. A., Conner, J. D., Holmes, K. K.: Double blind controlled trial of topical acyclovir in genital herpes simplex virus infections. American Journal of Medicine 1982, 73 (Supplement 1A): 326–334.
Reichman, R. C., Badger, G. J., Mertz, G. J., Corey, L., Richman, D. D., Connor, J. D., Redfield, D., Savoia, M. C., Oxman, M. N., Bryson, Y., Tyrrell, D. L., Portnoy, J., Creigh-Kirk, T., Keeney, R. E., Ashikaga, T., Dolin, R.: Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial. Journal of the American Medical Association 1984, 251: 2103–2107.
Douglas, J. M., Critchlow, C., Benedetti, J., Mertz, G. J., Conner, J. D., Hintz, M. A., Fahnlander, A., Remington, M., Winter, C., Corey, L.: A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. New England Journal of Medicine 1984, 310: 1551–1556.
Halsos, A. M., Salo, O. P., Lassus, A., Tjotta, E. A. L., Havi, T., Gabrielsen, B., Fiddian, A. P.: Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled crossover study. Acta Dermato-Venereologica 1985, 65: 59–63.
Mindel, A., Faherty, A., Hindley, D., Adler, M. W., Weller, I. V. D., Sutherland, S., Fiddian, A. P.: Prophylactic oral acyclovir in recurrent genital herpes. Lancet 1986, ii: 57–59.
Straus, S. E., Takiff, H. E., Mindell, S., Seidlin, M., Bachrach, S., Lininger, L., DiGiovanna, J. J., Western, K. A., Smith, H. A., Nusinoff-Lehrman, S., Creagh-Kirk, T., Alling, D.W.: Suppression of frequently recurring genital herpes; a placebo controlled double blind trial of oral acyclovir. New England Journal of Medicine 1984, 310: 1545–1550.
Mindel, A., Faherty, A., Carney, O., Patou, G., Freris, M., Williams, P.: Long term suppressive acyclovir therapy — dosage and safety in patients with recurrent genital herpes. Lancet 1988, i: 926–928.
Mertz, G., Jones, C., Mills, J., Fife, K. H., Lemon, S., Stapleton, J. T., Hill, E. L., Davis, L. G., and the Acyclovir Study Group: Long term acyclovir suppression of frequently recurring genital herpes simplex virus infection: a multicenter double blind trial. Journal of the American Medical Association 1988, 260 (Supplement 2): 201–206.
Rooney, J. F., Felser, J. M., Ostrove, J. M., Strause, S. E.: Acquisition of genital herpes from an asymptomatic sexual partner. New England Journal of Medicine 1986, 34: 1561–1564.
Tucker, W. E.: Preclinical toxicology of acyclovir: an overview. American Journal of Medicine, Acyclovir Symposium, 1982, p. 27–30.
Douglas, J. M., Davis, L. G., Remington, M. L., Paulsen, C. A., Perrin, E. B., Goodman, P., Conner, J. D., King, D., Corey, L.: A double-blind placebo-controlled trial of the effect of chronic oral acyclovir on sperm production in men with frequently recurrent genital herpes. Journal of Infectious Diseases 1988, 157: 588–593.
Gold, D., Corey, L.: Acyclovir prophylaxis for herpes simplex virus infection. Antimicrobial Agents and Chemotherapy, 1987, 361–367.
Straus, S. E., Seidlin, M., Takiff, H. E., Rooney, J. F., Nusinoff-Lehrman, S., Bachrach, S., Felser, J. M., Giovanna, J. J., Grimes, G. J., Krakauer, H., Hallanan, C., Alling, D.: Double blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes. Antiviral Research 1986, 6: 151 – 159.
Shepp, D. H., Dandliker, P. S., Flournoy, N., Meyers, J. D.: Once-daily intravenous acyclovir tor prophylaxis of herpes simplex virus reactivation after marrow transplantation. Journal of Antimicrobial Chemotherapy 1985, 16: 389–395.
Brown, Z. A., Vontver, L. A., Benedetti, J., Critchlow, C. W., Sells, C. J., Berry, S., Corey, L.: Effects on the infants of first episode genital herpes during pregnancy. New England Journal of Medicine 1987, 317: 1247–1251.
Lagrew, D. C., Furlow, T. G., Hager, D., Yarrish, D. L.: Dissemianted herpes simplex virus infection in pregnancy: succesful treatment with acyclovir. Journal of the American Medical Association 1984, 252: 2038–2039.
Coen, D. M., Schaffer, P. A.: Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proceedings of the National Academy of Sciences of the USA 1980, 77: 2265–2269.
Crumpacker, C. S., Schnipper, L. E., Marlowe, S. I., Kowalsky, P. N., Hershey, B. J., Levin, M. J.: Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. New England Journal of Medicine 1982, 306: 343–346.
Barry, D. W., Lehrman, S. N., Ellis, M. N.: Clinical and laboratory experience with acyclovir-resistant herpesviruses. Journal of Antimicrobial Chemotherapy 1986, 18 (Supplement B): 75–84.
Dekker, C., Ellis, M. N., McLaren, C., Hunter, G., Rogers, J., Barry, D. W.: Virus resistance in clinical practice. Journal of Antimicrobial Chemotherapy 1983, 12 (Supplement B): 137–152.
Burns, W. H., Santos, G. W., Leitman, P. S., Sarai, R., Laskin, O. L., McLaren, C., Barry, D.W.: Isolation and characterization of resistant herpes simplex virus after acylcovir therapy. Lancet 1982, i: 421–423.
Field, H. J., Darby, G.: Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrobial Agents and Chemotherapy 1980, 17: 209–216.
Parris, D. S., Harrington, J. E.: Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrobial Agents and Chemotherapy 1982, 22: 71–77.
McLaren, C., Corey, L., Dekker, C., Barry, D. W.: In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir treated patients. Journal of Infectious Diseases 1983, 148: 868–875.
Meyers, J. D.: Treatment of herpesvirus infections in the immunocompromised host. Scandinavian Journal of Infectious Disease 1985, Supplement 47: 128–136.
Nusinoff-Lehrman, S., Douglas, J. M., Corey, L., Barry, D. W.: Recurrent genital herpes and suppressive oral acyclovir therapy: relationship between clinical outcome and in vitro drug sensitivity. Annals of Internal Medicine 1986, 104: 786–790.
Division of Sexually Transmitted Diseases, Center for Prevention Services, Centers for Disease Control: Genital herpes infection — United States, 1966–1984. Morbidity and Mortality Weekly Report 1986, 35: 402–404.
Chuang, T.Y., Su, W. P. D., Perry, H. O., Ilstrup, D. M., Kurland, L. T.: Incidence and trend of herpes progenitalis: a 15 year population study. Mayo Clinic Proceedings 1983, 58: 436–441.
Sullivan-Bolyai, J., Hull, H. F., Wilson, C., Corey, L.: Neonatal herpes simplex virus infections in King County, Washington, Journal of the American Medical Association 1983, 250: 3059–3062.
Corey, L., Spear, P. G.: Infections with herpes simplex viruses. Parts I and II. New England Journal of Medicine 1986, 314: 686–691.
Corey, L., Spear, P. G.: Infections with herpes simplex viruses. Parts I and II. New England Journal of Medicine 1986, 314: 749–757.
Stevens, J. G., Wagner, E. K., Rao, G. B., Cook, M. L., Feldman, L. T.: RNA complementary to a herpes virus alpha gene mRNA is prominent in latently infected neurons. Science 1987, 235: 1056–1059.
Croen, K. D., Ostrove, J. M., Dragovic, L. J., Smialek, J. E., Straus, S. E.: Latent herpes simplex virus in human trigeminal gnaglia: detection of an immediate early gene “anti-sense” transcript by in situ hybridization. New England Journal of Medicine 1987, 317: 1427–1432.
Mertz, G. J., Schmidt, O., Jourden, J. L., Guinan, M. E., Remington, M. L., Fahnlander, A., Winter, C., Holmes, K. K., Corey, L.: Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sexually Transmitted Diseases 1985, 12: 33–39.
Mertz, G. J., Coombs, R. W., Ashley, R., Jourden, J., Remington, M., Winter, C., Fahnlander, A., Guinan, M., Ducey, H., Corey, L.: Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. Journal of Infectious Diseases 1988, 157: 1169–1177.
Moore, D.E., Zarutskie, P. W., Soules, M. R., Ashley, R., Dragavon, J., Remington, M., Corey, L.: Transmission of genital herpes by artificial insemination with a donor experiencing asymptomatic primary HSV-2 infection. Journal of the American Medical Association (in press).
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1989 Springer Fachmedien Wiesbaden
About this chapter
Cite this chapter
Corey, L. (1989). Current Status of Antiviral Chemotherapy for Genital Herpes Simplex Virus Infection: Its Impact on Disease Control. In: Jackson, G.G., Schlumberger, H.D., Zeiler, H.J. (eds) Perspectives in Antiinfective Therapy. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-322-86064-4_29
Download citation
DOI: https://doi.org/10.1007/978-3-322-86064-4_29
Publisher Name: Vieweg+Teubner Verlag, Wiesbaden
Print ISBN: 978-3-528-07979-6
Online ISBN: 978-3-322-86064-4
eBook Packages: Springer Book Archive